SXSW 2025
Healthcare’s Blindspot? Offering Women of Color Higher-Tech
Description:
“Good enough” treatment isn’t good enough – the healthcare system is often missing the mark for women of color. This critical discussion on unequal access to cutting-edge treatments and how some pharma innovators are changing that in rare disease. We'll explore why higher-tech treatments aren’t being suggested for this audience, and what marketers are doing to make the option clear to women directly. Panelists will discuss the specific needs of women of color and showcase innovative solutions for more equitable access to advanced healthcare. Leave with actionable steps to bridge the gap.
Other Resources / Information
Takeaways
- How unconscious bias impacts access to high-tech treatments for women of color.
- The importance of diversity in clinical trials for better healthcare outcomes
- Actionable solutions to improve access and representation in clinical research.
Speakers
- Bindu Gopalan, Executive Vice President, Client Leader, Ogilvy Health
- Robert Hillman, Head of US marketing Immunology, AstraZeneca
Organizer
Tara Mullins, EVP, Ogilvy Health
SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.
Add Comments